comparemela.com

Latest Breaking News On - Eitan naor - Page 1 : comparemela.com

Sumitomo-backed IN Venture raises $70m for 2nd VC fund

The Israeli venture capital fund has announced the first closing of its $150 million second fund.

Annual Israel-Japan event mourns Shinzo, praises relations between the two nations

Annual Israel-Japan Event Mourns Shinzo, Praises Relations Between the Two Nations

Annual Israel-Japan Event Mourns Shinzo, Praises Relations Between the Two Nations
algemeiner.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from algemeiner.com Daily Mail and Mail on Sunday newspapers.

Big in Japan conference highlights Israel-Japan tech cooperation

Big in Japan conference highlights Israel-Japan tech cooperation
globes.co.il - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globes.co.il Daily Mail and Mail on Sunday newspapers.

Genoox accelerates genomic data community platform expansion with $8M round and appointment of new Board Chair

(0) PALO ALTO, Calif., June 1, 2021 /PRNewswire/ Genoox, the world s first community-driven genomic data platform, announced today that it has raised $8 million in a round led by IN Venture, a Sumitomo Corporation backed venture fund, with participation from Infinity Medical and existing investors Inimiti, Glilot Capital and Triventures. The new investment will enable the company to expand its community of genetic professional users, reaching over 1500 healthcare organizations today, enhancing the network effect created by sharing genetic insights on the Genoox platform. Our investment in Genoox is a clear reflection of our belief that genomic data will become the backbone of the precision medicine revolution , says Eitan Naor, Managing Partner & Co Founder at IN Venture. Digital Health is one of our focus investment pillars highly aligned with Sumitomo Corporation strategy to meaningfully impact society. Genoox s deep-tech and unique approach to building a world-class communi

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.